Blis Technologies Limited — Earnings Release 2025

Aug 17, 2025

BLIS Technologies Limited 399 Moray Place, Dunedin, New Zealand, 9016 blis.co.nz info@blis.co.nz

==> picture [86 x 52] intentionally omitted <==

18 August 2025

Revenue growth with one off cost pressures impacting profitability

BLIS Technologies Limited (BLIS) delivers revenue of $3.5m for the first quarter ending 30 June 2025 (1Q26), an increase of $0.1m on the same period last year. 1Q26 EBITDA is a $0.2m loss compared to a $0.5m profit for 1Q25.

1Q26 results are characterised by growth in Private Label revenues and strong New Zealand wholesale revenues leading into winter. Total ingredient revenues were down compared to the same period last year, impacted by the timing of orders for one of our larger customers, but will rebound this quarter.

1Q26 earnings have been impacted by one-off cost increases within the supply chain. The oneoff cost increase is forecast to be $0.9m in the full year FY26 with $0.7m impacting the Q1 result. Q1 EBITDA is a $0.5m profit on an underlying basis excluding one-off costs (Q1 2025 $0.5m).

“Based on current market indicators, we are forecasting revenue in 1HY26 will be around $7.5m, driven by a strengthening of ingredient revenues. This represents an increase of 25% from 1HY25. EBITDA (inclusive of one-off costs) for 1HY26 is expected to be a profit slightly below the same period last year (1HY25 $0.3m).

“The timing of ingredient sales and the one-off costs in the supply chain have impacted the Q1 result. An improved Q2 result will offset the lower Q1 trading result. At this stage we are forecasting revenue growth of between 10% and 15% for the full year FY26” said Scott Johnson, CEO.

Ends

For further information, please contact:

Scott Johnson CEO +64 21 488 831

About BLIS Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS[®] products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz.

==> picture [86 x 52] intentionally omitted <==

BLIS Technologies Limited 399 Moray Place, Dunedin, New Zealand, 9016 blis.co.nz info@blis.co.nz

Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics